Will IO Biotech (NASDAQ:IOBT) Spend Its Cash Wisely? [Yahoo! Finance]
IO Biotech, Inc. (IOBT)
Company Research
Source: Yahoo! Finance
For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. So should IO Biotech NASDAQ:IOBT ) shareholders be worried about its cash burn? In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. Let's start with an examination of the business' cash, relative to its cash burn. See our latest analysis for IO Biotech When Might IO Biotech Run Out Of Money? A company's cash runway is calculated by dividing its cash hoard by its cash burn. When IO Biotech last reported its March 2024 balance sheet in May 2024, it had zero debt and cash worth US$118m. Looking at the last year, the company burnt through US$72m. So it had a cash run
Show less
Read more
Impact Snapshot
Event Time:
IOBT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IOBT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IOBT alerts
High impacting IO Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
IOBT
News
- IO Biotech to Present at Jefferies Global Healthcare ConferenceGlobeNewswire
- IO Biotech, Inc. (NASDAQ: IOBT) had its price target raised by analysts at HC Wainwright from $8.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- IO Biotech Reports First Quarter 2024 Financial Results and Provides Business HighlightsGlobeNewswire
- IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewswire
- IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness [Yahoo! Finance]Yahoo! Finance
IOBT
Earnings
- 5/14/24 - Beat
IOBT
Sec Filings
- 6/11/24 - Form 8-K
- 6/7/24 - Form 4
- 6/7/24 - Form 4
- IOBT's page on the SEC website